SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-438348
Filing Date
2013-11-12
Accepted
2013-11-12 16:34:21
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d600691d10q.htm 10-Q 614594
2 EX-10.1 d600691dex101.htm EX-10.1 125441
3 EX-31.1 d600691dex311.htm EX-31.1 9208
4 EX-31.2 d600691dex312.htm EX-31.2 9628
5 EX-32.1 d600691dex321.htm EX-32.1 5395
  Complete submission text file 0001193125-13-438348.txt   5052698

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT aria-20130930.xml EX-101.INS 624560
7 XBRL TAXONOMY EXTENSION SCHEMA aria-20130930.xsd EX-101.SCH 47628
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aria-20130930_cal.xml EX-101.CAL 70624
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aria-20130930_def.xml EX-101.DEF 297087
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE aria-20130930_lab.xml EX-101.LAB 388209
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aria-20130930_pre.xml EX-101.PRE 354661
Mailing Address 26 LANDSDOWNE CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE ST CAMBRIDGE MA 02139 6174940400
ARIAD PHARMACEUTICALS INC (Filer) CIK: 0000884731 (see all company filings)

IRS No.: 223106987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36172 | Film No.: 131210617
SIC: 2836 Biological Products, (No Diagnostic Substances)